In the world of oncology, advancements in treatment options often mark pivotal moments in patient care. Ivan Kairatov, a biopharma expert with profound knowledge in tech and innovation, shares insights into the nuanced landscape of smouldering multiple myeloma (SMM) and its treatment. With his
How is telehealth reshaping the future of cancer care for older adults? In rural areas where healthcare facilities are sparse, imagine an 80-year-old gentleman with sparkling eyes sitting comfortably in his favorite chair, meeting his oncologist virtually. He accesses his treatment plan from a
The latest advancements in healthcare interventions acknowledge the critical need for culturally sensitive strategies, especially within minority communities. Breast cancer survivors among the Latina demographic often encounter challenges specific to their cultural contexts. Addressing these needs
In recent years, remarkable advancements in imaging technologies have dramatically transformed the landscape of cancer treatment and research. These imaging breakthroughs have enabled scientists and clinicians to analyze how cancer cells respond to various drugs simultaneously, marking a leap
The US FDA's accelerated approval of Datroway (datopotamab deruxtecan) marks a notable advancement in the realm of lung cancer therapy. This approval is groundbreaking, as Datroway is the first TROP2-directed therapy sanctioned for lung cancer in the United States, specifically targeting a segment
Recent preclinical studies offer a glimmer of hope for millions battling formidable solid tumors. Nagoya University's breakthrough work in CAR-T cell therapy, focusing on the Eva1 protein, presents a potential paradigm shift. Amidst rising global cancer rates, these developments could redefine
